Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDr. Martens Regulatory News (DOCS)

Share Price Information for Dr. Martens (DOCS)

Share Price is delayed by 15 minutes
Get Live Data
70.20    0.90 (1.30%)
Bid:
69.90
Ask:
70.20
Spread: 0.30 (0.429%)
Market Cap: £671.87m
DOCS Live PriceLast checked at - London Stock Exchange

Intraday Dr. Martens Share Chart

Directorate Change

24 Mar 2023 07:00

RNS Number : 0822U
Dr. Martens PLC
24 March 2023
 

Dr. Martens plc

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Dr. Martens plc ('the Company') today announces that, following a comprehensive search and selection process, Andrew Harrison will join the Board as an Independent Non-Executive Director with effect from 1 May 2023.

 

Andrew is a managing partner at consumer brand investment firm Freston Ventures and Senior Independent Director at Ocado Group plc, proprietor of the Ocado Smart Platform and joint owner of online grocer Ocado Retail Limited, where he is also chair of the Remuneration Committee and designated Non-Executive Director for engagement with the workforce. He built his executive career over more than two decades at Carphone Warehouse, where he served as Chief Executive and Chair. As a member of the early founding team, he drove the growth and international expansion of Carphone Warehouse from a small, privately owned retailer to established market leader and FTSE constituent, subsequently leading the merger of the business with Dixons in 2014, where he was Deputy Chief Executive.

 

Paul Mason, Chairman, said:

 

"I am delighted to welcome Andrew to the Dr. Martens Board. He brings a wealth of expertise of consumer facing and technology focused businesses and a highly entrepreneurial mindset. His significant prior experience as both a Chief Executive and Non-Executive Director of large, listed companies will bolster the Board and will be invaluable to the business as we embark on the next chapter of the Dr. Martens story."

 

On joining the Board, Andrew will also become a member of the Audit, Remuneration and Nomination Committees.

 

The Company confirms that there is no further information required to be disclosed pursuant to paragraph 9.6.13 of the UK Listing Rules.

 

 

Enquiries

 

Investors and analysts

Mark Blythman, Interim Director of Investor Relations +44 7570 871207

mark.blythman@drmartens.com

Media

Gill Hammond, Director of Communications +44 7384 214248

 

H/Advisors Maitland

Rhys Jones +44 7881 996460

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

 

The Company listed successfully on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEAFUDEDSEED
Date   Source Headline
12th Sep 20235:07 pmRNSDirector/PDMR Shareholding
12th Sep 20234:32 pmRNSHolding(s) in Company
11th Sep 20236:22 pmRNSTransaction in Own Shares
8th Sep 20235:55 pmRNSTransaction in Own Shares
7th Sep 20236:01 pmRNSTransaction in Own Shares
5th Sep 20235:59 pmRNSTransaction in Own Shares
4th Sep 20236:16 pmRNSTransaction in Own Shares
1st Sep 20235:39 pmRNSTransaction in Own Shares
1st Sep 20239:47 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares
30th Aug 20235:51 pmRNSTransaction in Own Shares
29th Aug 20236:16 pmRNSTransaction in Own Shares
25th Aug 20236:22 pmRNSTransaction in Own Shares
24th Aug 20236:04 pmRNSTransaction in Own Shares
23rd Aug 20236:10 pmRNSTransaction in Own Shares
22nd Aug 20235:30 pmRNSTransaction in Own Shares
21st Aug 20235:46 pmRNSTransaction in Own Shares
18th Aug 20235:41 pmRNSTransaction in Own Shares
18th Aug 202310:01 amRNSDirector/PDMR Shareholding
17th Aug 20235:31 pmRNSTransaction in Own Shares
16th Aug 20235:29 pmRNSTransaction in Own Shares
15th Aug 20235:08 pmRNSTransaction in Own Shares
14th Aug 20235:30 pmRNSTransaction in Own Shares
14th Aug 20233:21 pmRNSDirector/PDMR Shareholding
11th Aug 20235:32 pmRNSTransaction in Own Shares
10th Aug 20235:39 pmRNSTransaction in Own Shares
9th Aug 20236:19 pmRNSTransaction in Own Shares
8th Aug 20235:43 pmRNSTransaction in Own Shares
7th Aug 20235:36 pmRNSTransaction in Own Shares
4th Aug 20235:52 pmRNSTransaction in Own Shares
3rd Aug 20235:46 pmRNSTransaction in Own Shares
2nd Aug 20235:41 pmRNSTransaction in Own Shares
1st Aug 20235:33 pmRNSTransaction in Own Shares
1st Aug 202311:15 amRNSTotal Voting Rights
31st Jul 20236:17 pmRNSTransaction in Own Shares
31st Jul 202311:25 amRNSHolding(s) in Company
28th Jul 20235:32 pmRNSTransaction in Own Shares
27th Jul 20235:33 pmRNSTransaction in Own Shares
26th Jul 20235:44 pmRNSTransaction in Own Shares
25th Jul 20235:21 pmRNSTransaction in Own Shares
24th Jul 20235:27 pmRNSTransaction in Own Shares
21st Jul 20235:30 pmRNSTransaction in Own Shares
20th Jul 20235:23 pmRNSTransaction in Own Shares
19th Jul 20234:26 pmRNSDirector/PDMR Shareholding
18th Jul 20235:10 pmRNSTransaction in Own Shares
17th Jul 20235:53 pmRNSTransaction in Own Shares
17th Jul 20238:57 amRNSDirector/PDMR Shareholding
14th Jul 20236:08 pmRNSTransaction in Own Shares
14th Jul 20233:15 pmRNSDirector Declaration
14th Jul 20237:00 amRNSCommencement of Share Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.